menu
    • menu
    [{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"University of Tampa","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Adenosine Triphosphate","moa":"Tyrosine-protein kinase ABL1; ATP-binding cassette sub-family C member 6; ATP-binding cassette sub-family C member 4; Multidrug resistance-associated protein 1; Cystic fibrosis transmembrane conductance regulator; Phosphatidylinositol 4,5-bisphosphate 3-k||Tyrosine-protein kinase ABL1; ATP-binding cassette sub-family C member 6; ATP-binding cassette sub-family C member 4; Multidrug resistance-associated protein 1; Cystic fibrosis transmembrane conductance regulator; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; Casein kinase II subunit alpha; Casein kinase II subunit beta; P2Y purinoceptor 11; Serine\/threonine-protein phosphatase 5; Tyrosine-protein kinase ABL2; Phospholipid-transporting ATPase ABCA1; Acetyl-coenzyme A synthetase, cytoplasmic; ALK tyrosine kinase receptor; NEDD8-activating enzyme E1 regulatory subunit; 5'-AMP-activated protein kinase catalytic subunit alpha-1; Serine\/threonine-protein kinase A-Raf; Activin receptor type-1-like; Long-chain-fatty-acid--CoA ligase 1; Cytosolic purine 5'-nucleotidase; ATPase GET3; ATP-binding cassette sub-family C member 9; RAC-alpha serine\/threonine-protein kinase; Beta-adrenergic receptor kinase 1; Apoptotic protease-activating factor 1; Acetyl-coenzyme A ","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ University of Tampa","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ University of Tampa"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Vanderbilt University | National Institute on Aging","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"2-hydroxybenzylamine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Vanderbilt University | National Institute on Aging","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"2-hydroxybenzylamine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Vanderbilt University | National Institute on Aging","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"2-hydroxybenzylamine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Vanderbilt University | National Institute on Aging","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"2-hydroxybenzylamine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Vanderbilt University | National Institute on Aging"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Beta-hydroxy-beta-methylbutyrate","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Undisclosed"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2012","type":"Inapplicable","leadProduct":"Bovine Albumin Concentrate","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Undisclosed"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Iowa State University","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2010","type":"Inapplicable","leadProduct":"Cahmb","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Metabolic Technologies \/ Iowa State University","highestDevelopmentStatusID":"6","companyTruncated":"Metabolic Technologies \/ Iowa State University"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2013","type":"Inapplicable","leadProduct":"Cahmb","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Metabolic Technologies \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Metabolic Technologies \/ Undisclosed"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"University of Tampa","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"HMB","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Metabolic Technologies \/ University of Tampa","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ University of Tampa"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"University of Central Florida","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2016","type":"Inapplicable","leadProduct":"HMB","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Metabolic Technologies \/ University of Central Florida","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ University of Central Florida"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Iowa State University","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"HMB","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase I","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Iowa State University","highestDevelopmentStatusID":"6","companyTruncated":"Metabolic Technologies \/ Iowa State University"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Iowa State University","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2015","type":"Inapplicable","leadProduct":"HMB","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Iowa State University","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Iowa State University"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Iowa State University","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2016","type":"Inapplicable","leadProduct":"HMB","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Iowa State University","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Iowa State University"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Koach Sport and Nutrition","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2015","type":"Inapplicable","leadProduct":"HMB-FA","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Koach Sport and Nutrition","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Koach Sport and Nutrition"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Iowa State University","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"PeakATP","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Iowa State University","highestDevelopmentStatusID":"6","companyTruncated":"Metabolic Technologies \/ Iowa State University"},{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Metabolic Technologies

    Menu

    Metabolic Technologies

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            2-HOBA: Multiple Dosing Study in Older Adults

                            Details : 2-hydroxybenzylamine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 14, 2018

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            2-HOBA: Multiple Dosing Study in Healthy Humans

                            Details : 2-hydroxybenzylamine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 13, 2018

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Brain Penetrance of 2-HOBA in Humans

                            Details : 2-hydroxybenzylamine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 12, 2018

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Metabolic Technologies

                            U.S.A arrow
                            BOS Manchester
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BOS Manchester
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            2-HOBA: Initial Evaluation in Humans

                            Details : 2-hydroxybenzylamine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            June 06, 2017

                            Lead Product(s) : 2-hydroxybenzylamine

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Vanderbilt University | National Institute on Aging

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMB

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : University of Central Florida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effects of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldie...

                            Details : HMB is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            May 05, 2016

                            Lead Product(s) : HMB

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : University of Central Florida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMB

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Undisclosed

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism

                            Details : HMB is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            March 23, 2016

                            Lead Product(s) : HMB

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Undisclosed

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMB

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Study Phase : Undisclosed

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of HMB Supplementation on Recovery Following ACL Surgery

                            Details : HMB is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anterior Cruciate Ligament Injuries.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            November 11, 2015

                            Lead Product(s) : HMB

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Highest Development Status : Undisclosed

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMB-FA

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Koach Sport and Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of 14-days of HMB-free Acid on Changes in Muscle During 4-days of Survival Training

                            Details : HMB-FA is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            July 20, 2015

                            Lead Product(s) : HMB-FA

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Koach Sport and Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Adenosine Triphosphate

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Sponsor : University of Tampa

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Follow...

                            Details : Adenosine-5'-Triphosphate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Myalgia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 21, 2014

                            Lead Product(s) : Adenosine Triphosphate

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Sponsor : University of Tampa

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed

                            Metabolic Technologies

                            U.S.A arrow
                            BioFit
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HMB

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase I

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2

                            Details : HMB is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Sarcopenia.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            January 23, 2014

                            Lead Product(s) : HMB

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase I

                            Sponsor : Iowa State University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth